Exhibit 107
Calculation of Filing Fee Table
Form S-3
Form Type
Evelo Biosciences, Inc.
(Exact Name of Registrant as Specified in its Charter
Table 1: Newly Registered Securities
| Security Type | Security Title |
Fee Calculation |
Amount Registered |
Proposed Maximum |
Maximum Aggregate Offering Price(1) |
Fee Rate |
Amount of Fee | |||||||||
| Fees to Be Paid | Equity | Common Stock, par value $0.001 per share |
457(c) | 13,189,836 | $9.63 | $127,018,120.68 | 0.0001102 | $13,997.40 | ||||||||
| Total Offering Amounts | $127,018,120.68 | $13,997.40 | ||||||||||||||
|
Total Fees Previously Paid | — | ||||||||||||||
| Total Fee Offsets | — | |||||||||||||||
| Net Fee Due | $13,997.40 | |||||||||||||||
| (1) |
Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) of the Securities Act, on the basis of the average of the high and low prices for a share of the registrant’s common stock as reported on the Nasdaq Capital Market on August 8, 2023, which date is a date within five business days prior to the filing of this registration statement. |